Expand Your Understanding.
Get Started
SubscribeLogin
Israel-Hamas Conflict
Pope Francis
Social Media
Baseball
Artificial Intelligence
Cricket
Premier League
Soccer
Natural Disasters
Donald Trump
Rugby
Vladimir Putin
European Union
Published • loading... • Updated

Protagonist Therapeutics Announces Plenary Presentation on VERIFY Phase 3 Study with Rusfertide at ASCO 2025

Summary by Weatherford Democrat
NEWARK, CA / ACCESS Newswire / April 23, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that an abstract was accepted for presentation at the Plenary Session at the American Society of Clinical Oncology (ASCO) Annual Meeting being…

4 Articles

All
Left
3
Center
Right
milescitystar.commilescitystar.com
+2 Reposted by 2 other sources
Lean Left

Protagonist Therapeutics Announces Plenary Presentation on VERIFY Phase 3 Study with Rusfertide at ASCO 2025

NEWARK, CA / ACCESS Newswire / April 23, 2025 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that an abstract was accepted for presentation at the Plenary Session at the American Society of Clinical Oncology (ASCO) Annual Meeting being…

Read Full Article
eastmud.comeastmud.com

Affimed Announces Three Abstracts Accepted for Presentation at the American Society of Clinical Oncology Annual Meeting – EastMud

(SeaPRwire) – Mannheim, Germany, April 23, 2025 — Affimed N.V.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Weatherford Democrat broke the news in on Wednesday, April 23, 2025.
Sources are mostly out of (0)

Similar News Topics

Newark, California

Newark, California

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal